Vanguard Group Inc Spring Works Therapeutics, Inc. Transaction History

Vanguard Group Inc

$5.57 Trillion
Q4 2024

A detailed history of Vanguard Group Inc transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 7,158,871 shares of SWTX stock, worth $339 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,158,871

Previous 6,713,278 6.64%

Holding current value

$339 Million

Previous $215 Million 20.25%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	BUY	$28.61 - $42.55 $12.7 Million - $19 Million	445,593 Added 6.64%	7,158,871 $259 Million
Q3 2024 Nov 13, 2024	BUY	$32.04 - $42.76 $5.41 Million - $7.22 Million	168,865 Added 2.58%	6,713,278 $215 Million
Q2 2024 Aug 13, 2024	BUY	$36.06 - $47.62 $544,073 - $718,490	15,088 Added 0.23%	6,544,413 $247 Million
Q1 2024 May 10, 2024	BUY	$36.5 - $52.5 $18 Million - $25.9 Million	492,783 Added 8.16%	6,529,325 $321 Million
Q4 2023 Feb 14, 2024	BUY	$18.94 - $37.24 $21.1 Million - $41.5 Million	1,114,080 Added 22.63%	6,036,542 $220 Million
Q3 2023 Nov 14, 2023	BUY	$23.12 - $31.38 $477,451 - $648,028	20,651 Added 0.42%	4,922,462 $114 Million
Q2 2023 Aug 14, 2023	BUY	$23.15 - $32.71 $11.4 Million - $16.1 Million	493,284 Added 11.19%	4,901,811 $129 Million
Q1 2023 May 15, 2023	BUY	$24.97 - $34.05 $2.15 Million - $2.93 Million	86,172 Added 1.99%	4,408,527 $113 Million
Q4 2022 Feb 10, 2023	BUY	$21.73 - $28.72 $24.5 Million - $32.3 Million	1,126,310 Added 35.24%	4,322,355 $112 Million
Q3 2022 Nov 14, 2022	BUY	$24.1 - $39.66 $10.9 Million - $17.9 Million	451,928 Added 16.47%	3,196,045 $91.2 Million
Q2 2022 Aug 12, 2022	SELL	$18.36 - $60.07 $2.51 Million - $8.22 Million	-136,869 Reduced 4.75%	2,744,117 $67.6 Million
Q1 2022 May 13, 2022	BUY	$48.97 - $65.46 $914,465 - $1.22 Million	18,674 Added 0.65%	2,880,986 $163 Million
Q4 2021 Feb 14, 2022	BUY	$53.3 - $75.84 $8,208 - $11,679	154 Added 0.01%	2,862,312 $177 Million
Q3 2021 Nov 12, 2021	BUY	$62.66 - $88.26 $9.78 Million - $13.8 Million	156,091 Added 5.77%	2,862,158 $182 Million
Q2 2021 Aug 13, 2021	BUY	$67.45 - $85.63 $183 Million - $232 Million	2,706,067 New	2,706,067 $223 Million

Others Institutions Holding SWTX

# of Institutions

236

Shares Held

67.3M

Call Options Held

260K

Put Options Held

316K

View Full List

About SpringWorks Therapeutics, Inc.

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.96B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

More about SWTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Spring Works Therapeutics, Inc. Transaction History